These lab-created options weren't made with leisure use in mind. While in the nineties, John W. Huffman and also a group of fellow chemists at Clemson University designed many of the initially formulas for synthetic cannabinoid receptor agonists (SCRAs), a household of substances that imitate the physiological and psychological impacts of cannabis